PKN605, Placebo to PKN605 50 mg film-coated tablets
CPKN605A12201
Phase 2 small_molecule active
Quick answer
PKN605, Placebo to PKN605 50 mg film-coated tablets for Atrial Fibrillation is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Atrial Fibrillation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active